Semaglutide is a GLP-1 receptor agonist, compounded by a licensed U.S. pharmacy and prescribed for weight management alongside diet and exercise. It acts on appetite signals the gut and the brain already use, which is what makes it a medical treatment rather than a supplement. A licensed provider reviews every request and prescribes only when treatment is appropriate for you.
Studied for appetite signaling
Semaglutide is a GLP-1 receptor agonist: the pathways under study are satiety signaling, how quickly the stomach empties, and glucose-dependent insulin release.




